forum

KOPRAN Share Price Discussion

Kopran Ltd.
Sector: Pharmaceuticals and health care
... Read more
KOPRAN Share Price *
31.95 +1.1 (3.57%)
* (quote may be delayed)

KOPRAN Discussion Forum

Kopran Consolidated June 2019 Net Sales at Rs 84.15 crore, up 38.98% Y-o-Y
www.moneycontrol.com
Like
reply
Reply
share
Share
Kopran Standalone June 2019 Net Sales at Rs 37.74 crore, up 36.35% Y-o-Y
moneycontrol.com
Like
reply
Reply
share
Share
Like
reply
Reply
share
Share
  • KOPRAN - Share Price - Fundamentals

    keyboard_arrow_down
    Market Capitalization238.52
    Enterprise Value289.12
    Price to Earnings50.64
    Price to Book Value1.16
    Return on Capital Employed0.05
    Return on Equity0.02
    Face Value10
    Dividend YieldNA
  • KOPRAN Share Price - Technicals

    keyboard_arrow_down
    KOPRAN - 52 Week High₹53.25
    KOPRAN - 52 Week Low₹25.5
  • KOPRAN Share Price - Historical (₹)

    keyboard_arrow_down
    DateOpenHighLowClose
    Sep 1630.8532.830.3532.3
    Sep 1331.531.830.230.85
    Sep 1231.9533.330.6531
    Sep 1130.1532.830.1531.8
    Sep 928.253228.0531.05
  • KOPRAN Share Price - Daily Moving Averages (DMA)

    keyboard_arrow_down
    20 Day Moving Average₹29.02
    30 Day Moving Average₹29.57
    50 Day Moving Average₹31.65
    100 Day Moving Average₹34.89
    200 Day Moving Average₹37.19
  • KOPRAN - Profit And Loss

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Revenue153.7181.54-0.15
    Operating Profit8.9517.36-0.48
    Profit Before Tax6.9613.1-0.47
    Net Income4.7112.87-0.63
  • KOPRAN - Balance Sheet

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Shareholder's Funds205.75209.52-0.02
    Total Liabilities99.85109.53-0.09
    Total Assets305.6310.47-0.02
  • KOPRAN - Cash Flow

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17 % Change
    Cash from Operating Activity15.776.481.43
    Cash from Investing Activity-5.21-8.88-0.41
    Cash from Financing Activity-10.712.36-5.54
    Net Cash Flow-0.15-0.042.75
  • KOPRAN - Ratios

    keyboard_arrow_down
    CONSOLIDATEDMar-18Mar-17
    Return on Assets0.020.04
    Return on Equity0.020.06
    Return on Capital Employed0.050.09
  • KOPRAN - 3 year Growth

    keyboard_arrow_down
    3 Year CAGR Growth in Revenue-0.53
    3 Year CAGR Growth in Operating Profit-0.72
    3 Year CAGR Growth in EBIDTA-0.56
    3 Year CAGR Growth in Net Income-0.7
    3 Yr CAGR Growth - Diluted EPS-0.71
  • KOPRAN - 5 year Growth

    keyboard_arrow_down
    5 Year CAGR Growth in Revenue-0.39
    5 Year CAGR Growth in Operating Profit-0.74
    5 Year CAGR Growth in EBIDTA-0.53
    5 Year CAGR Growth in Net Income-0.61
    3 Yr CAGR Growth - Diluted EPS-0.65
  • KOPRAN Share Price - Recent News

    keyboard_arrow_down
    NewsBot
    Aug 9 12:13 AM
    Kopran Consolidated June 2019 Net Sales at Rs 84.15 crore, up 38.98% Y-o-Y
    www.moneycontrol.com
    NewsBot
    Aug 9 12:13 AM
    Kopran Standalone June 2019 Net Sales at Rs 37.74 crore, up 36.35% Y-o-Y
    moneycontrol.com
    NewsBot
    Jun 13 1:18 PM
    NewsBot
    Jan 22 1:17 AM
    NewsBot
    Jan 22 1:17 AM
  • KOPRAN - Related Communities

    keyboard_arrow_down
    Wanbury Ltd. Sector: Pharmaceuticals ...
    Piramal Phytocare Ltd. Sector: Pharma...
    Parabolic Drugs Ltd. Sector: Pharmace...
    Orchid Pharma Ltd. Sector: Pharmaceut...
    Biofil Chemicals & Pharmaceuticals Lt...
    Wockhardt Ltd. Sector: Pharmaceutical...
    Vivimed Labs Ltd. Sector: Pharmaceuti...
    Venus Remedies Ltd. Sector: Pharmaceu...
    Unichem Laboratories Ltd. Sector: Pha...
    TTK Healthcare Ltd. Sector: Pharmaceu...
SOURCE: Data from D'Market via Quandl. Intraday data delayed 15 minutes.
DISCLAIMER: Information is provided "as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.